9/24/20 Leaderboard Pharma
 

Bell-More Labs, Inc.

Rating: 0 - Write A Review
4030 Gill Avenue, P.O. Box 179
Hampstead, MD 21074-0179
About Bell-More Labs, Inc.
  • We are independent. Bell-More is completely independent, not part of a larger company. Actually we are one of the few companies in the United States with our capabilities that is independent. Every customer gets the same personalized attention.

    We observe confidentiality. Confidentiality is assured so that your products, formulations, and processes will remain yours.

    We have the equipment. From our Stokes freeze dryers to our RAB enclosed Chase-Logman filler, we utilize state of the art equipment. Our operation is housed in a recently updated building. The equipment and facilities are completely validated and operated in compliance with Current Good Manufacturing Procedures.

    We are responsive. You can count on us for prompt proposals and quick answers to inquiries. We strive to minimize red tape; turnaround is fast, and pricing is competitive.
Competitors of Bell-More Labs, Inc.

  • Lifecore Biomedical

    Lifecore Biomedical is the global leader in manufacturing and supplying sodium hyaluronate (NaHy). Over the past 30 years, more than 90 million patients have benefited from our certified pharmaceutical grade NaHy. We are using our expertise in handling highly viscous solutions to expand our... Read More

  • Ardena

    Ardena is your one-source partner to help you navigate the drug development process from molecule to clinic. We offer an integrated, flexible service encompassing drug substance production, dosage form manufacture, clinical logistics, bioanalysis and dossier development. We are also at the... Read More

  • Alcami Corporation

    AAIPharma Services Corp. is a leading provider of services that encompass the entire pharmaceutical drug development process from early development through commercialization. The company, which has the benefit of more than 30 years of experience, specializes in analytical chemistry, formulation...
Pharma_3:1_5.7.19
3/12- Pharm. 3:1
Pharma 10/26/2018